DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gv8qwl/global_nonsmall) has announced the addition of the "Global Non-small Cell Lung Cancer Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Non-small Cell Lung Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Non-small Cell Lung Cancer market. It covers active Non-small Cell Lung Cancer pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Non-small Cell Lung Cancer - Disease Overview
2. Non-small Cell Lung Cancer Pipeline Overview
3. Non-small Cell Lung Cancer Phase 3 Clinical Trial Pipeline Insights
4. Non-small Cell Lung Cancer Phase 2 Clinical Trial Pipeline Insights
5. Non-small Cell Lung Cancer Phase 1 Clinical Trial Pipeline Insights
6. Non-small Cell Lung Cancer Preclinical Research Pipeline Insights
7. Non-small Cell Lung Cancer Discovery Stage Pipeline Insights
8. Non-small Cell Lung Cancer Drug Development Activities - Geographic Landscape
8.1. Non-small Cell Lung Cancer R&D Activities in North America
8.2. Non-small Cell Lung Cancer R&D Activities in Europe
9. Non-small Cell Lung Cancer Pipeline - Licensing Activities
Table 1. Non-small Cell Lung Cancer Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Non-small Cell Lung Cancer Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Non-small Cell Lung Cancer Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Non-small Cell Lung Cancer Pipeline Molecules - Preclinical Research
Table 5. Non-small Cell Lung Cancer Pipeline Molecules - Drug Discovery
Table 6. Non-small Cell Lung Cancer R&D Activities by Geography
Table 7. Non-small Cell Lung Cancer Pipeline Molecules - North America
Table 8. Non-small Cell Lung Cancer Pipeline Molecules - Europe
Table 9. Non-small Cell Lung Cancer Pipeline - Licensing Activities
Figure 1. Non-small Cell Lung Cancer Pipeline Molecules by R&D Stage
Figure 2. Non-small Cell Lung Cancer R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/gv8qwl/global_nonsmall